ClearPath (@ClearPath100) profile picture

Particular focus on bio, fintech, deeptech and broader vertical AI themes.

Joined March 2025
Photo by ClearPath (@ClearPath100)Photo by ClearPath (@ClearPath100)Photo by ClearPath (@ClearPath100)Photo by ClearPath (@ClearPath100)Photo by ClearPath (@ClearPath100)
ClearPath retweeted
this is pretty funny, and an on point description of the first day to first wk post event dynamics this fall, which are a bit of a mess. fortunately things seem to have started to improve.
You mean you don't appreciate when your biotech holding with fantastic data is up 40% in the premarket with 50% more upside to fair value, and then gets crushed to flat at open because risk at a large MM market sold a pod's holdings for blowing up on a MRNA short position, and then a quant momentum strategy shorts it because of the big pullback, and then a quant fund piles on the selling pressure by hedging their AI long trade by shorting interest rate risk out with a SMID cap biotech short, and then the stock is down 15% and no one knows why so an analyst publishes that obviously the stock is down because (pick random datapoint that doesn't matter) but in reality was just persuaded on a call with a pod PM to be bearish because they had a short position they needed to press and then that narrative gets entrenched and you're sitting here wondering why this company swung 60% down on great data and is financed through CF+ and trades at a big discount to some other biotech company and the world moves on to the next company with data tomorrow and no one cares to re-visit your company because it's a "catalyst desert" for 3 months? And pharma then passes over it and buys an undifferentiated pre-clinical private China asset instead of your company, which blows up on them a year later and they write it down but now your company needs to finance at a discount to the prior data? How could you not love that?
2
47
5,012
ClearPath retweeted
As some may say, there's a new Marshall in town
$qure $clpt Per @LogicalValueMx It’s time, it’s Marshall time.
1
20
2,580
Do you believe now?
975
2,479
347
32,941
1,379,186
ClearPath retweeted
Made on Earth by humans
6,061
18,154
1,459
227,746
7,278,319
ClearPath retweeted
Biology is not just a Rube Goldberg Turing Machine but so much more, because when you look at what the molecules really are and how they push - why it's electric forces, and the chemical bonds are electronic too, and all these molecules and atoms are bathed in a common sea of electromagnetism that does not just travel fast rather it defines the speed of causality. And that these chemical bonds and molecular rotations all vibrate, DC electric fields wiggling into AC fields, and these AC fields travel as photons and land as phonons heating things up, making and breaking bonds, changing their shape, we feel this as heat, as light, and our bodies are made of towering stacks of electronic bonds each with its own energy level that are so closely spaced as to be continuous, and all these bonds and molecules vibrating and emitting and absorbing constitute a constant exchange of field energy and information with the towering stacks of electronic bonds in our surroundings, like tall ships with endless stories of cannons exchanging electromagnetic broadsides in both directions at once, at all times, along minimal paths in spacetime, at quantized energy levels. And you'd rightly think this is all wondrously mad and fantastical and surely just a mathematical model and I say no - this is sight, this is what it means to see, both literally and figuratively, to know that your experience is constituted by electromagnetic field interaction in its entirety, and these same fields are what planets, stars, everything is made of, and when you open two quarter sized holes in your head and let it all in this is what you *see*. The world as constructed in your mind, the surface of your retina coupled to the surface of the wall, a cloud, a distant galaxy by a field wiggling both ends at once. Now you consider all these things and what energy means, and how it flows through the body and the air and environment as a currency animating dead matter into life, that it comes from the Sun, ultimately, crushing protons into Helium and bathing the solar system in it's electromagnetic field of life giving energy, passed as photons and minted by chloroplasts into sugar, and if you really start to visualize and understand the true nature of what you're in, what the constituent building blocks of everyday experience actually turn out to be in the details, then you know for certain that humans are like children playing on the shore of an ocean so deep and wide as to make our greatest imagination and dreams seem shallow. And that the laws of nature are as much for our discovery as we are to be a discovery of the universe getting to know itself.
35
70
8
542
23,420
ClearPath retweeted
$QURE’s platform franchise era has officially begun. A 1 of 1 HD asset and more to come. Stay tuned.
7
4
91
10,199
ClearPath retweeted
80-90% For those lazy to search $qure
Y'all r crazy for $qure being up <10% premarket on this. Just google approval rate for accepted BLA with PR and do the math Added a bunch at 27$, oversize me
2
7
1,088
ClearPath retweeted
Happy November! This month Voyager 1 will become the first spacecraft to reach 1 light day from Earth. 🔭 #astro
111
2,545
225
14,463
1,661,518
ClearPath retweeted
Investor tribes of North America!
Fitness tribes of North America!
22
19
6
502
117,465
ClearPath retweeted
Not many people seem to know about Metaplanet, Jaan Tallinn's VC firm. They are the most AGI-pilled firm on the planet, and are about to flip many of the tier 1s. > Invested in @GoogleDeepMind in 2011 > Led @AnthropicAI series A in 2021 > Doubled down on Anthropic in every round since. IRR hurdle for deploying capital into anything else was {absurdly high number}% for years > Anchored the premier AGI hedge funds (+Mythos) + in-house public equities strategy 4-person team in Estonia now managing 10s of billions AUM, liquid after $ANT IPO. Rationalist roots --> zero bureaucracy, cares about human survival & flourishing as north star, doesn't care who else is investing or how high status a founder / idea is Founders: congrats! you no longer need to play status games to raise a mega round for your civilization-scale moonshot. You can just pitch @metaplanetfund
13
18
5
375
43,621
ClearPath retweeted
Revenue per GPU can increase as token prices decline if per GPU token throughput increases enough. So both Anthropic revenue *and* margins can go up as token prices go down *if* GPU prices go up less than the product of (token price decline * per GPU throughput increase). But I have super enjoyed all the commentary to the contrary!
113
116
27
1,771
197,147
Succession is so damn good
112
1,441
162
23,392
2,056,398
ClearPath retweeted
Adam the contrast was the point. Two different bad/fatal diseases yet very different response from the field to advances. We do not have a functional cure for many cancers but HR < .7 in any cancer is described as practice changing in oncology. Neurology seems underwhelmed by the same degree in disease change. Of course cancer is not one thing and I could have been more precise- CLL is not good but now mostly not fatal, due to many advances from Lilly and our peers HR+ HER - breast cancer has long survival now yet GI cancers are mostly unsolved and survival curves are terrible. You know what else is terrible? Almost every neuro-degenerative disease including AD and we (including the media) need to discuss it that way. Unfortunately I’ve witnessed end of life journeys up close in both diseases, while different horrors present themselves in each I’d say they are both pretty bad. Advancement 30%+ at a time should change practice and routinely be offered to patients and families. Oncology does this Neurology doesn’t.
$LLY Kisunla is an Alzheimer's drug. It's not a cancer drug. Different diseases, different trajectories, different patient population with different needs, different benefit-risk profile. @DaveARicks, speaking to @bradloncar, points to the hazard ratio from Kisunla's Phase 3 studies and says, "If this was a cancer drug, it would be a giant drug!" Ok, but it's not.
33
17
15
349
54,251
He really did it. He built a fucking flying car.
280
789
230
13,108
1,883,465
ClearPath retweeted
Cool!
In partnership with Vinod Khosla (@vkhosla), I’m proud to introduce Reservoir. Billionaires have owned their cells for years. Starting today, you can too. Sign up today: withreservoir.com
3
7
1
37
5,350
ClearPath retweeted
$qure $clpt The new framework is intended to enable patient input at earlier stages and at milestones throughout the development and review process. It also aims to provide greater clarity and consistency to drug developers on regulatory decision making. The agency said in a statement that it should take into account what evidence is reasonably attainable, given the nature of rare diseases.
New: FDA leadership is kicking off a top-to-bottom review of how it approaches approvals for drugs to treat rare diseases. The Rare Disease Framework Initiative will kick off with a meeting on Oct. 28 w/ @RobertLangreth 🎁: bloomberg.com/news/articles/…
1
4
3
41
4,080
ClearPath retweeted
Korolev - Ice polar city of mars
27
85
3
1,143
30,883
ClearPath retweeted
My thoughts on why I believe QURE has cleared the bar. Free post below. botn.bio/p/the-three-year-qu…
5
7
5
119
12,230
ClearPath retweeted
Starship Flight 14
Starship Flight 14, the first morning launch from Starbase since Flight 5
1,262
1,556
168
15,774
3,668,812
ClearPath retweeted
👇👇👇
Replying to @Vulpescap
And why wouldn’t it get approved? The endpoint submitted for approval is stat Sig, as was the key secondary that will serve as the confirmatory primary. I actually have a hard time seeing how people think this gets shut out with the current admin/setup?
2
1
23
6,145